J Am Soc Nephrol 2019 12 24;30(12):2473-2474. Epub 2019 Oct 24.
Department of Medical Informatics, Amsterdam Public Health Research Institute, European Society of Paediatric Nephrology/European Renal Association and European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and.
Catheter Cardiovasc Interv 2021 Apr 15. Epub 2021 Apr 15.
Columbia University Division of Cardiology at Mount Sinai Medical Center, Miami Beach, Florida, USA.
Objectives: To assess the outcomes following transcatheter edge-to-edge mitral valve repair (TMVr) in patients with chronic kidney disease (CKD).Background: Percutaneous TMVr is beneficial in high surgical risk patients with severe mitral regurgitation (MR). However, those with CKD are not well studied. Read More
Brain 2021 Apr 15. Epub 2021 Apr 15.
Department of Pathology and Cell Biology, Division of Neuropathology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, and the New York Presbyterian Hospital, New York, NY, 10032, USA.
Many patients with SARS-CoV-2 infection develop neurological signs and symptoms, though, to date, little evidence exists that primary infection of the brain is a significant contributing factor. We present the clinical, neuropathological, and molecular findings of 41 consecutive patients with SARS-CoV-2 infections who died and underwent autopsy in our medical center. The mean age was 74 years (38-97 years), 27 patients (66%) were male and 34 (83%) were of Hispanic/Latinx ethnicity. Read More
J Public Health Res 2021 Apr 14;10(2). Epub 2021 Apr 14.
School of Nursing, Faculty of Medicine, Universitas Brawijaya, Malang.
Background: Chronic kidney disease (CKD) is defined as a progressive disease that causes renal failure and requires extended and long-term therapies. CKD patients need to choose one of these therapies to improve their quality of life. This study aims to investigate differences in the quality of life of chronic kidney disease patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis (CAPD). Read More
Front Immunol 2021 29;12:607204. Epub 2021 Mar 29.
Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Peritoneal fibrosis is characterized by abnormal production of extracellular matrix proteins leading to progressive thickening of the submesothelial compact zone of the peritoneal membrane. This process may be caused by a number of insults including pathological conditions linked to clinical practice, such as peritoneal dialysis, abdominal surgery, hemoperitoneum, and infectious peritonitis. All these events may cause acute/chronic inflammation and injury to the peritoneal membrane, which undergoes progressive fibrosis, angiogenesis, and vasculopathy. Read More
J Am Soc Nephrol 2021 Apr 14. Epub 2021 Apr 14.
Department of Bioethics and Humanities, University of Washington, Seattle, Washington.
Background: variants contribute to the markedly higher incidence of ESKD in Blacks compared with Whites. Genetic testing for these variants in patients with African ancestry who have nephropathy is uncommon, and no specific treatment or management protocol for -associated nephropathy currently exists.Methods: A multidisciplinary, racially diverse group of 14 experts and patient advocates participated in a Delphi consensus process to establish practical guidance for clinicians caring for patients who may have -associated nephropathy. Read More